FDA Orange Book · active-ingredient family
Chromic chloride
Chromic chloride is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CHROMIC CHLORIDE IN PLASTIC CONTAINER · NDA 018961
2
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CHROMIC CHLORIDE IN PLASTIC CONTAINERRLD | HOSPIRA | NDA 018961 | AP | Jun 26, 1986 | |
| CHROMIC CHLORIDE | ABRAXIS PHARM | NDA 019271 | — | May 05, 1987 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CHROMIC CHLORIDE | SOMERSET THERAPS LLC | ANDA 218538 | AP | Nov 18, 2024 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Chromic chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

